In Minneapolis, the New York Yankees are optimistic about Anthony Volpe’s return to form following a cortisone shot administered during the All-Star break. The initial injection seemed to provide immediate relief, leading to high hopes for Volpe after a second shot last week. In his first start back, he made a notable impact, going 2-for-4 with a double, a walk, and one RBI in a thrilling 10-9 victory over the Minnesota Twins at Target Field.
“It felt great,” Volpe remarked, reflecting on his return to the lineup after a week on the sidelines. His enthusiasm was palpable, especially after witnessing the game from the bench. “All these games are big. It felt good to get out there.” His performance not only contributed to the team’s win but also showcased his potential to reclaim his starting position at shortstop.
The Yankees had turned to José Caballero during Volpe’s absence, who had started six consecutive games in his place. This shift was partly due to Volpe’s recovery from a partially torn labrum, which had been affecting his play prior to the cortisone treatments. Manager Aaron Boone characterized the competition for the shortstop position as a “day to day” situation, emphasizing the team’s need for Volpe to regain his footing in the final weeks of the regular season.
Boone’s decision to start Volpe again was strategic, aimed at reintegrating him into the lineup while also considering Caballero’s limited playing time. Notably, Caballero had not seen six consecutive starts since May 2024, making this a pivotal moment for both players. Boone expressed satisfaction with Volpe’s immediate contributions, noting, “Good to see him get some immediate results with a double the other way, a walk, base hit.”
Volpe himself acknowledged the significant improvements following the cortisone injection. “It feels like when we do all the treatments and all the stuff that actually works,” he explained. This sentiment resonates with many athletes who experience similar frustrations when dealing with injuries, particularly those that linger and impact performance. The mental strain of rehabilitation can be just as taxing as the physical challenges, and Volpe’s journey highlights the resilience required to return to peak condition.
The lingering question remains: how much did his shoulder injury hinder his performance prior to the cortisone shots? Volpe felt he was capable of pushing through the discomfort until he aggravated the injury on September 7. “Just where we were at in the season, there was going to be no good time to feel better,” he stated, illustrating the difficult decisions athletes often face in balancing pain management with performance demands.
As the Yankees gear up for the final stretch of the season, the urgency for Volpe to sustain his success is palpable. The team believes that a healthy Volpe is essential for their postseason aspirations, with his presence at shortstop enhancing their overall lineup while allowing Caballero to serve as a valuable asset off the bench. With only two weeks left in the regular season, the stakes are high, and both players will be critical in navigating the challenges ahead.